🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study assesses the efficacy of neoadjuvant treatment with pyrotinib and...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2021-06-03
Trial ID
NCT04717531
Treatments Being Tested
This is a Phase II clinical trial evaluating the benefit from therapy with ...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00507741
Treatments Being Tested
Myelomeningocele is a neural tube defect that occurs between the third and ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-09-02
Trial ID
NCT04035863
Treatments Being Tested
The aim of this project is to develop and validate NTCP-models for complica...
Status
Recruiting
Location
Radboud UMC
Start Date
2023-02-01
Trial ID
NCT06366828
Treatments Being Tested
Chronic pain is a global public health problem, which intensifies even more...
Status
Recruiting
Location
Gastric Outpatient Clinic of HC-UFG
Start Date
2023-07-28
Trial ID
NCT05816798
Treatments Being Tested
The purpose of this study is to demonstrate that virologically controlled H...
Status
Completed
Location
Local Institution
Start Date
2002-06
Trial ID
NCT00135382
The objective of the HeartFlow ADVANCE Registry is to evaluate utility, cli...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02499679
This research is NOT part of an interventional trial, however the investiga...
Status
Unknown
Location
Laboratory of Renal Physiology, Meir Medical Center ,
Start Date
2013-02
Trial ID
NCT01423279
This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-05-14
Trial ID
NCT03126916
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052